109 related articles for article (PubMed ID: 33964352)
1. Comparison of Clinical Efficacy of Neoadjuvant Chemoradiation Therapy Between Lower and Higher Radiation Doses for Carcinoma of the Esophagus and Gastroesophageal Junction: A Systematic Review.
Li Y; Liu H; Sun C; Yin X; Tong J; Zhang X; Wang X; Yuan X; Zhang Z; Lu G; Gu Y; Li Y; Huang T; Qiao Z; Chen Y
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):405-416. PubMed ID: 33964352
[TBL] [Abstract][Full Text] [Related]
2. Optimal radiation dosing in concurrent neoadjuvant chemoradiation for resectable esophageal cancer: a meta-analysis.
Engel S; Awerbuch A; Kwon D; Picado O; Yechieli R; Yakoub D; Portelance L
J Gastrointest Oncol; 2019 Jun; 10(3):391-399. PubMed ID: 31183187
[TBL] [Abstract][Full Text] [Related]
3. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Shi JM; Li N; Jiang LM; Yang L; Wang SL; Song YW; Liu YP; Fang H; Lu NN; Qi SN; Chen B; Li YX; Zhao DB; Tang Y; Jin J
Sci Rep; 2024 Mar; 14(1):7522. PubMed ID: 38553594
[TBL] [Abstract][Full Text] [Related]
4. Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines.
Anker CJ; Dragovic J; Herman JM; Bianchi NA; Goodman KA; Jones WE; Kennedy TJ; Kumar R; Lee P; Russo S; Sharma N; Small W; Suh WW; Tchelebi LT; Jabbour SK
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):186-200. PubMed ID: 32858113
[TBL] [Abstract][Full Text] [Related]
5. The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis.
Luo D; Zhong Q; Zhu X
Cancer Biol Ther; 2023 Dec; 24(1):1-10. PubMed ID: 36519807
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients.
Mantziari S; Farinha HT; Messier M; Winiker M; Allemann P; Ozsahin EM; Demartines N; Piessen G; Schäfer M
Ann Surg Oncol; 2024 Apr; 31(4):2499-2508. PubMed ID: 38198002
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer.
Innocente R; Navarria F; Petri R; Palazzari E; Vecchiato M; Polesel J; Ziccarelli A; Martino A; Ubiali P; Tonin D; Lauretta A; Belluco C; Foltran L; Buonadonna A; Lleshi A; Colombo CB; Barresi L; Gigante M; Franchin G; De Paoli A
Front Oncol; 2021; 11():626275. PubMed ID: 33680967
[TBL] [Abstract][Full Text] [Related]
8. Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy.
Yang Y; Xu X; Zhou X; Bao W; Zhang D; Gu F; Du X; Chen Q; Qiu G
Front Oncol; 2020; 10():1431. PubMed ID: 32974158
[No Abstract] [Full Text] [Related]
9. High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis.
Sun X; Wang L; Wang Y; Kang J; Jiang W; Men Y; Hui Z
Front Oncol; 2020; 10():1222. PubMed ID: 32850362
[No Abstract] [Full Text] [Related]
10. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study.
Gertsen EC; van der Veen A; Brenkman HJF; Brosens LAA; van der Post RS; Verhoeven RHA; Luijten JCHBM; Vissers PAJ; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP
Ann Surg Oncol; 2024 Mar; 31(3):1760-1772. PubMed ID: 38127213
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer.
Populaire P; Defraene G; Nafteux P; Depypere L; Moons J; Isebaert S; Haustermans K
Acta Oncol; 2023 Nov; 62(11):1488-1495. PubMed ID: 37643135
[TBL] [Abstract][Full Text] [Related]
12. A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial.
Gao T; Yang Y; Zhang Z; Yang Y; Liu S; Hu Y; Zhu Y; Yang H; Fu J; Wang J; Lin T; Xi M; Li Q; Liu M; Zhao L
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):809-820. PubMed ID: 37210047
[TBL] [Abstract][Full Text] [Related]
13. What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis.
Chen Y; Zhu HP; Wang T; Sun CJ; Ge XL; Min LF; Zhang XW; Jia QQ; Yu J; Yang JQ; Allgayer H; Abba ML; Zhang XZ; Sun XC
Oncotarget; 2017 Oct; 8(51):89095-89107. PubMed ID: 29179502
[TBL] [Abstract][Full Text] [Related]
14. Biophysical Characterization of the Leukemic Bone Marrow Vasculature Reveals Benefits of Neoadjuvant Low-Dose Radiation Therapy.
Brooks J; Kumar B; Zuro DM; Raybuck JD; Madabushi SS; Vishwasrao P; Parra LE; Kortylewski M; Armstrong B; Froelich J; Hui SK
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):60-72. PubMed ID: 32841681
[TBL] [Abstract][Full Text] [Related]
15. Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer.
Lin F; Chen Y; Huang B; Ruan S; Lin J; Chen Z; Huang C; Zhao B
Front Pharmacol; 2024; 15():1391562. PubMed ID: 38783944
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective.
Yang Z; Guan F; Bronk L; Zhao L
Pharmacol Ther; 2024 Feb; 254():108591. PubMed ID: 38286161
[TBL] [Abstract][Full Text] [Related]
17. Palliative care for patients with gastroesophageal cancer at all stages: a narrative review.
DeCarli K; Guyer D; Almhanna K
Ann Palliat Med; 2024 Apr; ():. PubMed ID: 38600815
[TBL] [Abstract][Full Text] [Related]
18. Advances in Radiotherapy Management of Esophageal Cancer.
Verma V; Moreno AC; Lin SH
J Clin Med; 2016 Oct; 5(10):. PubMed ID: 27775643
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy intensification for atypical and malignant meningiomas: A systematic review.
Gaito S; Goyal L; Rieu R; France A; Burnet NG; Barker C; Pan S; Colaco RJ; Minniti G; Roncaroli F; Smith E; Aznar M; Whitfield G
Neurooncol Pract; 2024 Apr; 11(2):115-124. PubMed ID: 38496911
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
